<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38131885</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2036-7430</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>Infectious disease reports</Title><ISOAbbreviation>Infect Dis Rep</ISOAbbreviation></Journal><ArticleTitle>Persisting Shadows: Unraveling the Impact of Long COVID-19 on Respiratory, Cardiovascular, and Nervous Systems.</ArticleTitle><Pagination><StartPage>806</StartPage><EndPage>830</EndPage><MedlinePgn>806-830</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/idr15060072</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19), instigated by the zoonotic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), rapidly transformed from an outbreak in Wuhan, China, into a widespread global pandemic. A significant post-infection condition, known as 'long- COVID-19' (or simply 'long- COVID'), emerges in a substantial subset of patients, manifesting with a constellation of over 200 reported symptoms that span multiple organ systems. This condition, also known as 'post-acute sequelae of SARS-CoV-2 infection' (PASC), presents a perplexing clinical picture with far-reaching implications, often persisting long after the acute phase. While initial research focused on the immediate pulmonary impact of the virus, the recognition of COVID-19 as a multiorgan disruptor has unveiled a gamut of protracted and severe health issues. This review summarizes the primary effects of long COVID on the respiratory, cardiovascular, and nervous systems. It also delves into the mechanisms underlying these impacts and underscores the critical need for a comprehensive understanding of long COVID's pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sideratou</LastName><ForeName>Christina-Michailia</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papaneophytou</LastName><ForeName>Christos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4045-8839</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Infect Dis Rep</MedlineTA><NlmUniqueID>101537203</NlmUniqueID><ISSNLinking>2036-7430</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE-2</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cytokine storm</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>8</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38131885</ArticleId><ArticleId IdType="pmc">PMC10742861</ArticleId><ArticleId IdType="doi">10.3390/idr15060072</ArticleId><ArticleId IdType="pii">idr15060072</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ramos-Casals M., Brito-Zer&#xf3;n P., Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat. Rev. Rheumatol. 2021;17:315&#x2013;332. doi: 10.1038/s41584-021-00608-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00608-z</ArticleId><ArticleId IdType="pmc">PMC8072739</ArticleId><ArticleId IdType="pubmed">33903743</ArticleId></ArticleIdList></Reference><Reference><Citation>McGowan V.J., Bambra C. COVID-19 mortality and deprivation: Pandemic, syndemic, and endemic health inequalities. The Lancet Public Health. 2022;7:e966&#x2013;e975. doi: 10.1016/S2468-2667(22)00223-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(22)00223-7</ArticleId><ArticleId IdType="pmc">PMC9629845</ArticleId><ArticleId IdType="pubmed">36334610</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;elik I., &#xd6;zt&#xfc;rk R. From asymptomatic to critical illness: Decoding various clinical stages of COVID-19. Turk. J. Med. Sci. 2021;51:3284&#x2013;3300. doi: 10.3906/sag-2107-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-2107-13</ArticleId><ArticleId IdType="pmc">PMC8771010</ArticleId><ArticleId IdType="pubmed">34445855</ArticleId></ArticleIdList></Reference><Reference><Citation>Balse E., Hatem S.N. Do cellular entry mechanisms of SARS-Cov-2 affect myocardial cells and contribute to cardiac injury in COVID-19 patients? Front. Physiol. 2021;12:630778. doi: 10.3389/fphys.2021.630778.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.630778</ArticleId><ArticleId IdType="pmc">PMC7985088</ArticleId><ArticleId IdType="pubmed">33767634</ArticleId></ArticleIdList></Reference><Reference><Citation>Markov P.V., Ghafari M., Beer M., Lythgoe K., Simmonds P., Stilianakis N.I., Katzourakis A. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 2023;21:361&#x2013;379. doi: 10.1038/s41579-023-00878-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-00878-2</ArticleId><ArticleId IdType="pubmed">37020110</ArticleId></ArticleIdList></Reference><Reference><Citation>Abulsoud A.I., El-Husseiny H.M., El-Husseiny A.A., El-Mahdy H.A., Ismail A., Elkhawaga S.Y., Khidr E.G., Fathi D., Mady E.A., Najda A., et al. Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions. Biomed. Pharmacother. 2023;157:113977. doi: 10.1016/j.biopha.2022.113977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113977</ArticleId><ArticleId IdType="pmc">PMC9637516</ArticleId><ArticleId IdType="pubmed">36370519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha N.K., Ojha S., Jha S.K., Dureja H., Singh S.K., Shukla S.D., Chellappan D.K., Gupta G., Bhardwaj S., Kumar N., et al. Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: A review on neurological impairments and manifestations. J. Mol. Neurosci. 2021;71:2192&#x2013;2209. doi: 10.1007/s12031-020-01767-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-020-01767-6</ArticleId><ArticleId IdType="pmc">PMC7814864</ArticleId><ArticleId IdType="pubmed">33464535</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan A.A., Smajlovi&#x107; S., Tombuloglu H., &#x106;ordi&#x107; S., Hajdarevi&#x107; A., Kudi&#x107; N., Al Mutai A., Turkistani S.A., Al-Ahmed S.H., Al-Zaki N.A., et al. SARS-CoV-2 infection and multi-organ system damage: A review. Biomol. Biomed. 2023;23:37&#x2013;52. doi: 10.17305/bjbms.2022.7762.</Citation><ArticleIdList><ArticleId IdType="doi">10.17305/bjbms.2022.7762</ArticleId><ArticleId IdType="pmc">PMC9901898</ArticleId><ArticleId IdType="pubmed">36124445</ArticleId></ArticleIdList></Reference><Reference><Citation>Abebe E.C., Dejenie T.A., Shiferaw M.Y., Malik T. The newly emerged COVID-19 disease: A systemic review. Virol. J. 2020;17:96. doi: 10.1186/s12985-020-01363-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01363-5</ArticleId><ArticleId IdType="pmc">PMC7341708</ArticleId><ArticleId IdType="pubmed">32641059</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li X., Li T., Zhang S., Wang L., Wu X., Liu J. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39:1629&#x2013;1635. doi: 10.1007/s10096-020-03899-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-03899-4</ArticleId><ArticleId IdType="pmc">PMC7180649</ArticleId><ArticleId IdType="pubmed">32333222</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker P.J., Siddell S.G., Lefkowitz E.J., Mushegian A.R., Adriaenssens E.M., Alfenas-Zerbini P., Davison A.J., Dempsey D.M., Dutilh B.E., Garc&#xed;a M.L., et al. Changes to virus taxonomy and to the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses. Arch. Virol. 2021;166:2633&#x2013;2648. doi: 10.1007/s00705-021-05156-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-05156-1</ArticleId><ArticleId IdType="pubmed">34231026</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitman M.R., Shaban M.V., Paniz-Mondolfi A.E., Sordillo E.M. Laboratory diagnosis of SARS-CoV-2 pneumonia. Diagnostics. 2021;11:1270. doi: 10.3390/diagnostics11071270.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11071270</ArticleId><ArticleId IdType="pmc">PMC8306256</ArticleId><ArticleId IdType="pubmed">34359353</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Rao Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat. Rev. Microbiol. 2021;19:685&#x2013;700. doi: 10.1038/s41579-021-00630-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00630-8</ArticleId><ArticleId IdType="pmc">PMC8447893</ArticleId><ArticleId IdType="pubmed">34535791</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller M., Volzke J., Subin B., Schmidt C.J., Geerdes-Fenge H., Reisinger E.C., M&#xfc;ller-Hilke B. Distinguishing incubation and acute disease stages of mild-to-moderate COVID-19. Viruses. 2022;14:203. doi: 10.3390/v14020203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020203</ArticleId><ArticleId IdType="pmc">PMC8875077</ArticleId><ArticleId IdType="pubmed">35215797</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B., Siqueira S., de Assis Soares W.R., de Souza Rangel F., Santos N.O., dos Santos Freitas A., Ribeiro da Silveira P., Tiwari S., Alzahrani K.J., G&#xf3;es-Neto A., et al. Long-COVID and post-COVID health complications: An up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13:700. doi: 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C., Bentivegna E., Cho S.-J., Harriott A.M., Garc&#xed;a-Azor&#xed;n D., Labastida-Ramirez A., Ornello R., Raffaelli B., Beltr&#xe1;n E.R., Ruscheweyh R., et al. Long COVID headache. J. Headache Pain. 2022;23:93. doi: 10.1186/s10194-022-01450-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogge M.M., Gautam B. COVID-19: Epidemiology and clinical practice implications. Nurse Pract. 2020;45:26&#x2013;34. doi: 10.1097/01.NPR.0000722312.25644.b9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.NPR.0000722312.25644.b9</ArticleId><ArticleId IdType="pmc">PMC7771524</ArticleId><ArticleId IdType="pubmed">33497081</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye A.D., Spence A.L., Mayerle M., Sardana N., Clay C.M., Eng M.R., Luedi M.M., Carroll Turpin M.A., Urman R.D., Cornett E.M. Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes. Best Pract. Res. Clin. Anaesthesiol. 2021;35:437&#x2013;448. doi: 10.1016/j.bpa.2021.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2021.02.003</ArticleId><ArticleId IdType="pmc">PMC7919539</ArticleId><ArticleId IdType="pubmed">34511231</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriatopoulou M., Korompoki E., Fotiou D., Ntanasis-Stathopoulos I., Psaltopoulou T., Kastritis E., Terpos E., Dimopoulos M.A. Organ-specific manifestations of COVID-19 infection. Clin. Exp. Med. 2020;20:493&#x2013;506. doi: 10.1007/s10238-020-00648-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-020-00648-x</ArticleId><ArticleId IdType="pmc">PMC7383117</ArticleId><ArticleId IdType="pubmed">32720223</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol. Rep. 2021;9:e14726. doi: 10.14814/phy2.14726.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazantzis D., Machairoudia G., Theodossiadis G., Theodossiadis P., Chatziralli I. Retinal microvascular changes in patients recovered from COVID-19 compared to healthy controls: A meta-analysis. Photodiagn. Photodyn. Ther. 2023;42:103556. doi: 10.1016/j.pdpdt.2023.103556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2023.103556</ArticleId><ArticleId IdType="pmc">PMC10072975</ArticleId><ArticleId IdType="pubmed">37023998</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilias I., Vassiliou A.G., Keskinidou C., Vrettou C.S., Orfanos S., Kotanidou A., Dimopoulou I. Changes in cortisol secretion and corticosteroid receptors in COVID-19 and non COVID-19 Critically Ill patients with sepsis/septic shock and scope for treatment. Biomedicines. 2023;11:1801. doi: 10.3390/biomedicines11071801.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11071801</ArticleId><ArticleId IdType="pmc">PMC10376106</ArticleId><ArticleId IdType="pubmed">37509441</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini D.M., Brunjes D.L., Lala A., Trivieri M.G., Contreras J.P., Natelson B.H. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. 2021;9:927&#x2013;937. doi: 10.1016/j.jchf.2021.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen N.W., Stiles L.E., Shaik R., Schneider L., Muppidi S., Tsui C.T., Geng L.N., Bonilla H., Miglis M.G. Characterization of autonomic symptom burden in long COVID: A global survey of 2314 adults. Front. Neurol. 2022;13:1012668. doi: 10.3389/fneur.2022.1012668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1012668</ArticleId><ArticleId IdType="pmc">PMC9639503</ArticleId><ArticleId IdType="pubmed">36353127</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns R., Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup. Med. 2005;55:20&#x2013;31. doi: 10.1093/occmed/kqi013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqi013</ArticleId><ArticleId IdType="pubmed">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e820. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H.E., Goldberg S.A., Forman C.A., Munter S.E., Hoh R., Tai V., et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome Coronavirus 2 infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutant E.-M., Meyrignac O., Beurnier A., Ja&#xef;s X., Pham T., Morin L., Boucly A., Bulifon S., Figueiredo S., Harrois A., et al. Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome. ERJ Open Res. 2022;8:00479&#x2013;02021. doi: 10.1183/23120541.00479-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00479-2021</ArticleId><ArticleId IdType="pmc">PMC8685862</ArticleId><ArticleId IdType="pubmed">35445129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Liu X., Zhou Y., Yu H., Li R., Zhan Q., Ni F., Fang S., Lu Y., Ding X., et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir. Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradian S.T., Parandeh A., Khalili R., Karimi L. Delayed symptoms in patients recovered from COVID-19. Iran. J. Public Health. 2020;49:2120&#x2013;2127. doi: 10.18502/ijph.v49i11.4729.</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/ijph.v49i11.4729</ArticleId><ArticleId IdType="pmc">PMC7917497</ArticleId><ArticleId IdType="pubmed">33708732</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L., Yang B., Jiang N., Fu W., He X., Zhou Y., Ma W.-L., Wang X. Three-month follow-up study of survivors of coronavirus disease 2019 after discharge. J. Korean Med. Sci. 2020;35:e418. doi: 10.3346/jkms.2020.35.e418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e418</ArticleId><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Cruz R.F., Waller M.D., Perrin F., Periselneris J., Norton S., Smith L.-J., Patrick T., Walder D., Heitmann A., Lee K., et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 2021;7:00655&#x2013;02020. doi: 10.1183/23120541.00655-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00655-2020</ArticleId><ArticleId IdType="pmc">PMC7585700</ArticleId><ArticleId IdType="pubmed">33575312</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M., Lv F., Huang Y., Xiao K. Follow-up study of the chest CT characteristics of COVID-19 survivors seven months after recovery. Front. Med. 2021;8:36298. doi: 10.3389/fmed.2021.636298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.636298</ArticleId><ArticleId IdType="pmc">PMC7956974</ArticleId><ArticleId IdType="pubmed">33732719</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J., Yang H., Lei P., Fan B., Qiu Y., Zeng B., Yu P., Lv J., Jian Y., Wan C. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge. J. X-ray Sci. Technol. 2020;28:383&#x2013;389. doi: 10.3233/XST-200685.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/XST-200685</ArticleId><ArticleId IdType="pmc">PMC7369060</ArticleId><ArticleId IdType="pubmed">32474479</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwensen H.F., Borreschmidt L.K., Storgaard M., Redsted S., Christensen S., Madsen L.B. Fatal pulmonary fibrosis: A post-COVID-19 autopsy case. J. Clin. Pathol. 2021;74:400&#x2013;402. doi: 10.1136/jclinpath-2020-206879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2020-206879</ArticleId><ArticleId IdType="pubmed">32723800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheware A., Ray A., Rana D., Bajpai P., Nambirajan A., Arulselvi S., Mathur P., Trikha A., Arava S., Das P., et al. ACE2 protein expression in lung tissues of severe COVID-19 infection. Sci. Rep. 2022;12:4058. doi: 10.1038/s41598-022-07918-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07918-6</ArticleId><ArticleId IdType="pmc">PMC8902283</ArticleId><ArticleId IdType="pubmed">35260724</ArticleId></ArticleIdList></Reference><Reference><Citation>Udwadia Z.F., Koul P.A., Richeldi L. Post-COVID lung fibrosis: The tsunami that will follow the earthquake. Lung India. 2021;38:S41&#x2013;S47. doi: 10.4103/lungindia.lungindia_818_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/lungindia.lungindia_818_20</ArticleId><ArticleId IdType="pmc">PMC8104338</ArticleId><ArticleId IdType="pubmed">33686978</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinz B., Lagares D. Evasion of apoptosis by myofibroblasts: A hallmark of fibrotic diseases. Nat. Rev. Rheumatol. 2020;16:11&#x2013;31. doi: 10.1038/s41584-019-0324-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-019-0324-5</ArticleId><ArticleId IdType="pmc">PMC7913072</ArticleId><ArticleId IdType="pubmed">31792399</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Wang L., Wang M., Zhou S., Lu Y., Cui H., Racanelli A.C., Zhang L., Ye T., Ding B., et al. Targeting fibrosis: Mechanisms and clinical trials. Signal Transduct. Target. Ther. 2022;7:206. doi: 10.1038/s41392-022-01070-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01070-3</ArticleId><ArticleId IdType="pmc">PMC9247101</ArticleId><ArticleId IdType="pubmed">35773269</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli C., Piccarducci R., Marchetti L., Romei C., Martini C. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: Lessons from post-COVID-19 patients. Biochem. Pharmacol. 2021;193:114812. doi: 10.1016/j.bcp.2021.114812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2021.114812</ArticleId><ArticleId IdType="pmc">PMC8546906</ArticleId><ArticleId IdType="pubmed">34687672</ArticleId></ArticleIdList></Reference><Reference><Citation>Dini F.L., Baldini U., Byty&#xe7;i I., Pugliese N.R., Bajraktari G., Henein M.Y. Acute pericarditis as a major clinical manifestation of long COVID-19 syndrome. Int. J. Cardiol. 2023;374:129&#x2013;134. doi: 10.1016/j.ijcard.2022.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.12.019</ArticleId><ArticleId IdType="pmc">PMC9734068</ArticleId><ArticleId IdType="pubmed">36513284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Xie X., Tu Z., Fu J., Xu D., Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct. Target. Ther. 2021;6:255. doi: 10.1038/s41392-021-00679-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00679-0</ArticleId><ArticleId IdType="pmc">PMC8261820</ArticleId><ArticleId IdType="pubmed">34234112</ArticleId></ArticleIdList></Reference><Reference><Citation>Basheer M., Saad E., Assy N. The cytokine storm in COVID-19: The strongest link to morbidity and mortality in the current epidemic. COVID. 2022;2:540&#x2013;552. doi: 10.3390/covid2050040.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid2050040</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdin S.M., Elgendy S.M., Alyammahi S.K., Alhamad D.W., Omar H.A. Tackling the cytokine storm in COVID-19, challenges and hopes. Life Sci. 2020;257:118054. doi: 10.1016/j.lfs.2020.118054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118054</ArticleId><ArticleId IdType="pmc">PMC7832727</ArticleId><ArticleId IdType="pubmed">32663575</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhya S., Rehman J., Malik A.B., Chen S. Mechanisms of lung injury induced by SARS-CoV-2 infection. Physiology. 2022;37:88&#x2013;100. doi: 10.1152/physiol.00033.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00033.2021</ArticleId><ArticleId IdType="pmc">PMC8873036</ArticleId><ArticleId IdType="pubmed">34698589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z., Peng F., Zhou Y. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19? Chin. Med. J. Pulm. Crit. Care Med. 2023;1:77&#x2013;83. doi: 10.1016/j.pccm.2022.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pccm.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9988550</ArticleId><ArticleId IdType="pubmed">37388822</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandolfi L., Fossali T., Frangipane V., Bozzini S., Morosini M., D&#x2019;Amato M., Lettieri S., Urtis M., Di Toro A., Saracino L., et al. Broncho-alveolar inflammation in COVID-19 patients: A correlation with clinical outcome. BMC Pulm. Med. 2020;20:301. doi: 10.1186/s12890-020-01343-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-020-01343-z</ArticleId><ArticleId IdType="pmc">PMC7668012</ArticleId><ArticleId IdType="pubmed">33198751</ArticleId></ArticleIdList></Reference><Reference><Citation>Barilli A., Visigalli R., Ferrari F., Bianchi M.G., Dall&#x2019;Asta V., Rotoli B.M. Immune-mediated inflammatory responses of alveolar epithelial cells: Implications for COVID-19 lung pathology. Biomedicines. 2022;10:618. doi: 10.3390/biomedicines10030618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10030618</ArticleId><ArticleId IdType="pmc">PMC8945544</ArticleId><ArticleId IdType="pubmed">35327420</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazar M., Barbu E.C., Chitu C.E., Tiliscan C., Stratan L., Arama S.S., Arama V., Ion D.A. Interstitial lung fibrosis following COVID-19 pneumonia. Diagnostics. 2022;12:2028. doi: 10.3390/diagnostics12082028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12082028</ArticleId><ArticleId IdType="pmc">PMC9407299</ArticleId><ArticleId IdType="pubmed">36010377</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthay M.A., Zemans R.L., Zimmerman G.A., Arabi Y.M., Beitler J.R., Mercat A., Herridge M., Randolph A.G., Calfee C.S. Acute respiratory distress syndrome. Nat. Rev. Dis. Primers. 2019;5:18. doi: 10.1038/s41572-019-0069-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-019-0069-0</ArticleId><ArticleId IdType="pmc">PMC6709677</ArticleId><ArticleId IdType="pubmed">30872586</ArticleId></ArticleIdList></Reference><Reference><Citation>Vianello A., Guarnieri G., Braccioni F., Lococo S., Molena B., Cecchetto A., Giraudo C., Bertagna De Marchi L., Caminati M., Senna G. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors. Clin. Chem. Lab. Med. 2022;60:307&#x2013;316. doi: 10.1515/cclm-2021-1021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-1021</ArticleId><ArticleId IdType="pubmed">34783228</ArticleId></ArticleIdList></Reference><Reference><Citation>Spagnolo P., Balestro E., Aliberti S., Cocconcelli E., Biondini D., Casa G.D., Sverzellati N., Maher T.M. Pulmonary fibrosis secondary to COVID-19: A call to arms? Lancet Respir. Med. 2020;8:750&#x2013;752. doi: 10.1016/S2213-2600(20)30222-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30222-8</ArticleId><ArticleId IdType="pmc">PMC7228737</ArticleId><ArticleId IdType="pubmed">32422177</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings M.J., Baldwin M.R., Abrams D., Jacobson S.D., Meyer B.J., Balough E.M., Aaron J.G., Claassen J., Rabbani L.E., Hastie J., et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study. Lancet. 2020;395:1763&#x2013;1770. doi: 10.1016/S0140-6736(20)31189-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31189-2</ArticleId><ArticleId IdType="pmc">PMC7237188</ArticleId><ArticleId IdType="pubmed">32442528</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake T.M., Riad A.M., Fairfield C.J., Egan C., Knight S.R., Pius R., Hardwick H.E., Norman L., Shaw C.A., McLean K.A., et al. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO clinical characterisation protocol UK: A prospective, multicentre cohort study. Lancet. 2021;398:223&#x2013;237. doi: 10.1016/S0140-6736(21)00799-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00799-6</ArticleId><ArticleId IdType="pmc">PMC8285118</ArticleId><ArticleId IdType="pubmed">34274064</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobler D.L., Pruzansky A.J., Naderi S., Ambrosy A.P., Slade J.J. Long-term cardiovascular effects of COVID-19: Emerging data relevant to the cardiovascular clinician. Curr. Atheroscler. Rep. 2022;24:563&#x2013;570. doi: 10.1007/s11883-022-01032-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-022-01032-8</ArticleId><ArticleId IdType="pmc">PMC9065238</ArticleId><ArticleId IdType="pubmed">35507278</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousif E., Premraj S. A review of long COVID with a special focus on its cardiovascular manifestations. Cureus. 2022;14:e31933. doi: 10.7759/cureus.31933.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.31933</ArticleId><ArticleId IdType="pmc">PMC9793803</ArticleId><ArticleId IdType="pubmed">36582565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning Q., Wu D., Wang X., Xi D., Chen T., Chen G., Wang H., Lu H., Wang M., Zhu L., et al. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct. Target. Ther. 2022;7:57. doi: 10.1038/s41392-022-00907-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00907-1</ArticleId><ArticleId IdType="pmc">PMC8863906</ArticleId><ArticleId IdType="pubmed">35197452</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit N.M., Churchill A., Nsair A., Hsu J.J. Post-acute COVID-19 syndrome and the cardiovascular system: What is known? Am. Heart J. Plus. 2021;5:100025. doi: 10.1016/j.ahjo.2021.100025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhao P., Tang D., Zhu T., Han R., Zhan C., Liu W., Zeng H., Tao Q., Xia L. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc. Imaging. 2020;13:2330&#x2013;2339. doi: 10.1016/j.jcmg.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., Jarvis H.C., et al. &#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T., Knight D.S., Razvi Y., Kumar K., Vimalesvaran K., Thornton G., Patel R., Chacko L., Brown J.T., Coyle C., et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur. Heart J. 2021;42:1866&#x2013;1878. doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Martin S., Shchendrygina A., Hoffmann J., Ka M.M., Giokoglu E., Vanchin B., Holm N., Karyou A., Laux G.S., et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat. Med. 2022;28:2117&#x2013;2123. doi: 10.1038/s41591-022-02000-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02000-0</ArticleId><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ar&#xe9;valos V., Ortega-Paz L., Rodr&#xed;guez-Arias J.J., Calvo L&#xf3;pez M., Castrillo-Golvano L., Salazar-Rodr&#xed;guez A., Sabat&#xe9;-Tormos M., Spione F., Sabat&#xe9; M., Brugaletta S. Acute and chronic effects of COVID-19 on the cardiovascular system. J. Cardiovasc. Dev. Dis. 2021;8:128. doi: 10.3390/jcdd8100128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd8100128</ArticleId><ArticleId IdType="pmc">PMC8541609</ArticleId><ArticleId IdType="pubmed">34677197</ArticleId></ArticleIdList></Reference><Reference><Citation>South A.M., Brady T.M., Flynn J.T. ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE inhibitor and Ang II (Angiotensin II) receptor blocker use during the pandemic. Hypertension. 2020;76:16&#x2013;22. doi: 10.1161/HYPERTENSIONAHA.120.15291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15291</ArticleId><ArticleId IdType="pmc">PMC7289676</ArticleId><ArticleId IdType="pubmed">32367746</ArticleId></ArticleIdList></Reference><Reference><Citation>Kai H., Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Hypertens. Res. 2020;43:648&#x2013;654. doi: 10.1038/s41440-020-0455-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-020-0455-8</ArticleId><ArticleId IdType="pmc">PMC7184165</ArticleId><ArticleId IdType="pubmed">32341442</ArticleId></ArticleIdList></Reference><Reference><Citation>Visco V., Vitale C., Rispoli A., Izzo C., Virtuoso N., Ferruzzi G.J., Santopietro M., Melfi A., Rusciano M.R., Maglio A., et al. Post-COVID-19 syndrome: Involvement and interactions between respiratory, cardiovascular and nervous Systems. J. Clin. Med. 2022;11:524. doi: 10.3390/jcm11030524.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030524</ArticleId><ArticleId IdType="pmc">PMC8836767</ArticleId><ArticleId IdType="pubmed">35159974</ArticleId></ArticleIdList></Reference><Reference><Citation>Catapano F., Marchitelli L., Cundari G., Cilia F., Mancuso G., Pambianchi G., Galea N., Ricci P., Catalano C., Francone M. Role of advanced imaging in COVID-19 cardiovascular complications. Insights Imaging. 2021;12:28. doi: 10.1186/s13244-021-00973-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13244-021-00973-z</ArticleId><ArticleId IdType="pmc">PMC7903405</ArticleId><ArticleId IdType="pubmed">33625637</ArticleId></ArticleIdList></Reference><Reference><Citation>Khasnavis S., Habib M., Kaawar F., Lee S., Capo A., Atoot A. New perspectives on Llong COVID syndrome: The development of unusually delayed and recurring pericarditis after a primary SARS-CoV-2 infection. Cureus. 2022;14:e25559. doi: 10.7759/cureus.25559.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.25559</ArticleId><ArticleId IdType="pmc">PMC9247740</ArticleId><ArticleId IdType="pubmed">35784959</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Zhu L., Sun L., Shao G. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries. Stem Cell Res. 2021;51:102168. doi: 10.1016/j.scr.2021.102168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2021.102168</ArticleId><ArticleId IdType="pmc">PMC7801189</ArticleId><ArticleId IdType="pubmed">33485182</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhmerov A., Marb&#xe1;n E. COVID-19 and the heart. Circ. Res. 2020;126:1443&#x2013;1455. doi: 10.1161/CIRCRESAHA.120.317055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317055</ArticleId><ArticleId IdType="pmc">PMC7188058</ArticleId><ArticleId IdType="pubmed">32252591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskar S., Sinha A., Banach M., Mittoo S., Weissert R., Kass J.S., Rajagopal S., Pai A.R., Kutty S. Cytokine storm in COVID-19-Immunopathological mechanisms, clinical considerations, and therapeutic approaches: The REPROGRAM consortium position paper. Front. Immunol. 2020;11:1648. doi: 10.3389/fimmu.2020.01648.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01648</ArticleId><ArticleId IdType="pmc">PMC7365905</ArticleId><ArticleId IdType="pubmed">32754159</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V., Stefanou M.-I., Demetriou M., Siafakas N., Makris M., Tsivgoulis G., Zoumpourlis V., Kympouropoulos S.P., Tsoporis J.N., Spandidos D.A., et al. Long COVID and neuropsychiatric manifestations. Exp. Ther. Med. 2022;23:363. doi: 10.3892/etm.2022.11290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanbehzadeh S., Tavahomi M., Zanjari N., Ebrahimi-Takamjani I., Amiri-arimi S. Physical and mental health complications post-COVID-19: Scoping review. J. Psychosom. Res. 2021;147:110525. doi: 10.1016/j.jpsychores.2021.110525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2021.110525</ArticleId><ArticleId IdType="pmc">PMC8133797</ArticleId><ArticleId IdType="pubmed">34051516</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M.I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C., et al. Neurological manifestations of long-COVID syndrome: A narrative review. Ther. Adv. Chronic. Dis. 2022;13:20406223221076890. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., Hu P., Guo L., Liu M., Xu J., et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T., Fietsam A.C., Deters J.R., Bryant A.D., Kamholz J. Post-COVID-19 fatigue: Potential contributing factors. Brain Sci. 2020;10:1012. doi: 10.3390/brainsci10121012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10121012</ArticleId><ArticleId IdType="pmc">PMC7766297</ArticleId><ArticleId IdType="pubmed">33352638</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., Doucet L., Berkani S., Oliosi E., Mallart E., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R., Rahman M.M., Rassel M.A., Monayem F.B., Sayeed S.K.J.B., Islam M.S., Islam M.M. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS ONE. 2021;16:e0249644. doi: 10.1371/journal.pone.0249644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249644</ArticleId><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dowds J., O&#x2019;Brien K., Sheill G., Dyer A.H., O&#x2019;Kelly B., Hynes J.P., Mooney A., Dunne J., Cheallaigh C.N., et al. Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Ann. Am. Thorac. Soc. 2021;18:997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Satici B., Gocet-Tekin E., Deniz M.E., Satici S.A. Adaptation of the fear of COVID-19 scale: Its association with psychological distress and life satisfaction in Turkey. Int. J. Ment. Health Addict. 2021;19:1980&#x2013;1988. doi: 10.1007/s11469-020-00294-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11469-020-00294-0</ArticleId><ArticleId IdType="pmc">PMC7207987</ArticleId><ArticleId IdType="pubmed">32395095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang F., Shen Y., Zhang X., Cen Y., Wang B., Zhao S., Zhou Y., Hu B., Wang M., et al. Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw. Open. 2021;4:e2127403. doi: 10.1001/jamanetworkopen.2021.27403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Cristillo V., Cotti Piccinelli S., Zoppi N., Bonzi G., Sattin D., Schiavolin S., Raggi A., Canale A., Gipponi S., et al. Long-term neurological manifestations of COVID-19: Prevalence and predictive factors. Neurol. Sci. 2021;42:4903&#x2013;4907. doi: 10.1007/s10072-021-05586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05586-4</ArticleId><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., Walshaw C., Kemp S., Corrado J., Singh R., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Arif G., Farhat A., Khazaal S., Annweiler C., Kovacic H., Wu Y., Cao Z., Fajloun Z., Khattar Z.A., Sabatier J.M. The renin-angiotensin system: A key role in SARS-CoV-2-induced COVID-19. Molecules. 2021;26:6945. doi: 10.3390/molecules26226945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26226945</ArticleId><ArticleId IdType="pmc">PMC8622307</ArticleId><ArticleId IdType="pubmed">34834033</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazaal S., Harb J., Rima M., Annweiler C., Wu Y., Cao Z., Abi Khattar Z., Legros C., Kovacic H., Fajloun Z., et al. The pathophysiology of long COVID throughout the renin-angiotensin system. Molecules. 2022;27:2903. doi: 10.3390/molecules27092903.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27092903</ArticleId><ArticleId IdType="pmc">PMC9101946</ArticleId><ArticleId IdType="pubmed">35566253</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Yachou Y., El Idrissi A., Belapasov V., Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: Understanding the neurological manifestations in COVID-19 patients. Neurol. Sci. 2020;41:2657&#x2013;2669. doi: 10.1007/s10072-020-04575-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04575-3</ArticleId><ArticleId IdType="pmc">PMC7385206</ArticleId><ArticleId IdType="pubmed">32725449</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuzzo D., Vasto S., Scalisi L., Cottone S., Cambula G., Rizzo M., Giacomazza D., Picone P. Post-acute COVID-19 neurological syndrome: A new medical challenge. J. Clin. Med. 2021;10:1947. doi: 10.3390/jcm10091947.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10091947</ArticleId><ArticleId IdType="pmc">PMC8124354</ArticleId><ArticleId IdType="pubmed">34062770</ArticleId></ArticleIdList></Reference><Reference><Citation>Futtrup J., Margolinsky R., Benros M.E., Moos T., Routhe L.J., Rungby J., Krogh J. Blood-brain barrier pathology in patients with severe mental disorders: A systematic review and meta-analysis of biomarkers in case-control studies. Brain Behav. Immun. 2020;6:100102. doi: 10.1016/j.bbih.2020.100102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100102</ArticleId><ArticleId IdType="pmc">PMC8474159</ArticleId><ArticleId IdType="pubmed">34589864</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay M.E., Madore C., Bordeleau M., Tian L., Verkhratsky A. Neuropathobiology of COVID-19: The role for glia. Front. Cell Neurosci. 2020;14:592214. doi: 10.3389/fncel.2020.592214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.592214</ArticleId><ArticleId IdType="pmc">PMC7693550</ArticleId><ArticleId IdType="pubmed">33304243</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Lu S., Chen J., Wei N., Wang D., Lyu H., Shi C., Hu S. The landscape of cognitive function in recovered COVID-19 patients. J. Psychiatr. Res. 2020;129:98&#x2013;102. doi: 10.1016/j.jpsychires.2020.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2020.06.022</ArticleId><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Koralnik I.J., Tyler K.L. COVID-19: A global threat to the nervous system. Ann. Neurol. 2020;88:1&#x2013;11. doi: 10.1002/ana.25807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25807</ArticleId><ArticleId IdType="pmc">PMC7300753</ArticleId><ArticleId IdType="pubmed">32506549</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dalahmah O., Thakur K.T., Nordvig A.S., Prust M.L., Roth W., Lignelli A., Uhlemann A.-C., Miller E.H., Kunnath-Velayudhan S., Del Portillo A., et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol. Commun. 2020;8:147. doi: 10.1186/s40478-020-01024-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01024-2</ArticleId><ArticleId IdType="pmc">PMC7447601</ArticleId><ArticleId IdType="pubmed">32847628</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., Ciceri F., Rovere-Querini P., Benedetti F. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Taga A., Lauria G. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era. J. Peripher. Nerv. Syst. 2022;27:4&#x2013;30. doi: 10.1111/jns.12482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12482</ArticleId><ArticleId IdType="pmc">PMC9115278</ArticleId><ArticleId IdType="pubmed">35137496</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselingh R., Wesselingh S.L. An eye to the future: Acute and long-term neuro-ophthalmological and neurological complications of COVID-19. Clin. Exp. Ophthalmol. 2023;51:370&#x2013;379. doi: 10.1111/ceo.14221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ceo.14221</ArticleId><ArticleId IdType="pubmed">36908238</ArticleId></ArticleIdList></Reference><Reference><Citation>Andalib S., Biller J., Di Napoli M., Moghimi N., McCullough L.D., Rubinos C.A., O&#x2019;Hana Nobleza C., Azarpazhooh M.R., Catanese L., Elicer I., et al. Peripheral nervous system manifestations associated with COVID-19. Curr. Neurol. Neurosci. Rep. 2021;21:9. doi: 10.1007/s11910-021-01102-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01102-5</ArticleId><ArticleId IdType="pmc">PMC7882462</ArticleId><ArticleId IdType="pubmed">33586020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaeley N., Kabi A., Pillai A., Shankar T., Ameena M.S.S. Post-COVID-19 Guillain-Barr&#xe9; syndrome: A case report with literature review. Cureus. 2022;14:e21246. doi: 10.7759/cureus.21246.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.21246</ArticleId><ArticleId IdType="pmc">PMC8842180</ArticleId><ArticleId IdType="pubmed">35178309</ArticleId></ArticleIdList></Reference><Reference><Citation>Filosto M., Cotti Piccinelli S., Gazzina S., Foresti C., Frigeni B., Servalli M.C., Sessa M., Cosentino G., Marchioni E., Ravaglia S., et al. Guillain-Barr&#xe9; syndrome and COVID-19: An observational multicentre study from two Italian hotspot regions. J. Neurol. Neurosurg. Psychiatry. 2021;92:751&#x2013;756. doi: 10.1136/jnnp-2020-324837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-324837</ArticleId><ArticleId IdType="pubmed">33158914</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragiel M., Mir&#xf3; &#xd2;., Llorens P., Jim&#xe9;nez S., Pi&#xf1;era P., Burillo G., Mart&#xed;n A., Mart&#xed;n-S&#xe1;nchez F.J., Garc&#xed;a-Lamberechts E.J., Jacob J., et al. Incidence, clinical, risk factors and outcomes of Guillain-Barr&#xe9; in Covid-19. Ann. Neurol. 2021;89:598&#x2013;603. doi: 10.1002/ana.25987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25987</ArticleId><ArticleId IdType="pubmed">33295021</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh J., Mukerji S.S., Collens S.I., Padera R.F., Jr., Pinkus G.S., Amato A.A., Solomon I.H. Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19. Neurology. 2021;97:e849&#x2013;e858. doi: 10.1212/WNL.0000000000012344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012344</ArticleId><ArticleId IdType="pubmed">34099523</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinna P., Grewal P., Hall J.P., Tavarez T., Dafer R.M., Garg R., Osteraas N.D., Pellack D.R., Asthana A., Fegan K., et al. Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline. J. Neurol. Sci. 2020;415:116969. doi: 10.1016/j.jns.2020.116969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116969</ArticleId><ArticleId IdType="pmc">PMC7832569</ArticleId><ArticleId IdType="pubmed">32570113</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganotti P., Bellavita G., D&#x2019;Acunto L., Tommasini V., Fabris M., Sartori A., Bonzi L., Buoite Stella A., Pesavento V. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barr&#xe9; syndrome and polyneuritis cranialis in COVID-19 patients: A case series. J. Med. Virol. 2021;93:766&#x2013;774. doi: 10.1002/jmv.26289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26289</ArticleId><ArticleId IdType="pmc">PMC7405169</ArticleId><ArticleId IdType="pubmed">32662899</ArticleId></ArticleIdList></Reference><Reference><Citation>Bureau B.L., Obeidat A., Dhariwal M.S., Jha P. Peripheral neuropathy as a complication of SARS-CoV-2. Cureus. 2020;12:e11452. doi: 10.7759/cureus.11452.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11452</ArticleId><ArticleId IdType="pmc">PMC7673277</ArticleId><ArticleId IdType="pubmed">33214969</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Mills A.J., Kelley M., Toran L.S., Smith B., Dalakas M.C., Nath A. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1146. doi: 10.1212/NXI.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler C.G.K., Allon S.J., Nyquist S.K., Mbano I.M., Miao V.N., Tzouanas C.N., Cao Y., Yousif A.S., Bals J., Hauser B.M., et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181:1016&#x2013;1035.e19. doi: 10.1016/j.cell.2020.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.035</ArticleId><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Silhol F., Sarlon G., Deharo J.-C., Va&#xef;sse B. Downregulation of ACE2 induces overstimulation of the renin&#x2013;angiotensin system in COVID-19: Should we block the renin&#x2013;angiotensin system? Hypertens. Res. 2020;43:854&#x2013;856. doi: 10.1038/s41440-020-0476-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-020-0476-3</ArticleId><ArticleId IdType="pmc">PMC7242178</ArticleId><ArticleId IdType="pubmed">32439915</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A., Ahirwar A.K., Sakarde A., Asia P., Gopal N., Alam S., Kaim K., Ahirwar P., Sorte S.R. COVID-19 and cardiovascular disease: A review of current knowledge. Horm. Mol. Biol. Clin. Investig. 2021;42:99&#x2013;104. doi: 10.1515/hmbci-2020-0052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hmbci-2020-0052</ArticleId><ArticleId IdType="pubmed">33544511</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza R.A.d., Nakamura P.M., Teixeira I.P., Souza M.T.d., Higino W.P. A probable relationship between physical exercise and COVID-19 mediated by the Renin-Angiotensin-Aldosterone System. Int. J. Cardiovasc. Sci. 2021;34:737&#x2013;741. doi: 10.36660/ijcs.20200188.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/ijcs.20200188</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.-j., Dong X., Cao Y.-y., Yuan Y.-d., Yang Y.-b., Yan Y.-q., Akdis C.A., Gao Y.-d. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75:1730&#x2013;1741. doi: 10.1111/all.14238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14238</ArticleId><ArticleId IdType="pubmed">32077115</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D., Salah Eldin H., Taeimah M., Khattab R., Salem R. The COVID-19 cytokine storm; what we know so far. Front. Immunol. 2020;11:1446. doi: 10.3389/fimmu.2020.01446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y.-M., Xu G., Wang B., Liu B.-C. Cytokine storm syndrome in coronavirus disease 2019: A narrative review. J. Intern. Med. 2021;289:147&#x2013;161. doi: 10.1111/joim.13144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13144</ArticleId><ArticleId IdType="pmc">PMC7404514</ArticleId><ArticleId IdType="pubmed">32696489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Tang G., Liu Y., Zhang L., Chen B., Han Y., Fu Z., Wang L., Hu G., Ma Q., et al. The role of IL-6 in coronavirus, especially in COVID-19. Front. Pharmacol. 2022;13:1033674. doi: 10.3389/fphar.2022.1033674.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.1033674</ArticleId><ArticleId IdType="pmc">PMC9727200</ArticleId><ArticleId IdType="pubmed">36506506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruenjaiman V., Sodsai P., Kueanjinda P., Bunrasmee W., Klinchanhom S., Reantragoon R., Tunvirachaisakul C., Manothummetha K., Mejun N., Liengswangwong K., et al. Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery. J. Microbiol. Immunol. Infect. 2022;55:993&#x2013;1004. doi: 10.1016/j.jmii.2022.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.09.001</ArticleId><ArticleId IdType="pmc">PMC9519362</ArticleId><ArticleId IdType="pubmed">36220753</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L., Orban Z.S., Koralnik I.J. Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence. Front. Med. 2022;9:1003103. doi: 10.3389/fmed.2022.1003103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1003103</ArticleId><ArticleId IdType="pmc">PMC9537824</ArticleId><ArticleId IdType="pubmed">36213654</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan I.H., Zahra S.A., Zaim S., Harky A. At the heart of COVID-19. J. Card. Surg. 2020;35:1287&#x2013;1294. doi: 10.1111/jocs.14596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.14596</ArticleId><ArticleId IdType="pubmed">32369872</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Duarte &#xc1;., Rivera-Izquierdo M., Guerrero-Fern&#xe1;ndez de Alba I., P&#xe9;rez-Contreras M., Fern&#xe1;ndez-Mart&#xed;nez N.F., Ruiz-Montero R., Serrano-Ortiz &#xc1;., Gonz&#xe1;lez-Serna R.O., Salcedo-Leal I., Jim&#xe9;nez-Mej&#xed;as E., et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: The ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021;19:129. doi: 10.1186/s12916-021-02003-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02003-7</ArticleId><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Usher K., Bhullar N., Jackson D. Life in the pandemic: Social isolation and mental health. J. Clin. Nurs. 2020;29:2756&#x2013;2757. doi: 10.1111/jocn.15290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.15290</ArticleId><ArticleId IdType="pubmed">32250493</ArticleId></ArticleIdList></Reference><Reference><Citation>Creese B., Khan Z., Henley W., O&#x2019;Dwyer S., Corbett A., Vasconcelos Da Silva M., Mills K., Wright N., Testad I., Aarsland D., et al. Loneliness, physical activity, and mental health during COVID-19: A longitudinal analysis of depression and anxiety in adults over the age of 50 between 2015 and 2020. Int. Psychogeriatr. 2021;33:505&#x2013;514. doi: 10.1017/S1041610220004135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610220004135</ArticleId><ArticleId IdType="pmc">PMC7985900</ArticleId><ArticleId IdType="pubmed">33327988</ArticleId></ArticleIdList></Reference><Reference><Citation>Reza-Zald&#xed;var E.E., Hern&#xe1;ndez-Sapi&#xe9;ns M.A., Minjarez B., G&#xf3;mez-Pinedo U., M&#xe1;rquez-Aguirre A.L., Mateos-D&#xed;az J.C., Matias-Guiu J., Canales-Aguirre A.A. Infection mechanism of SARS-COV-2 and its implication on the nervous system. Front Immunol. 2020;11:621735. doi: 10.3389/fimmu.2020.621735.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.621735</ArticleId><ArticleId IdType="pmc">PMC7878381</ArticleId><ArticleId IdType="pubmed">33584720</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan D., Du T., Hong W., Chen L., Que H., Lu S., Peng X. Neurological complications and infection mechanism of SARS-CoV-2. Signal Transduct. Target. Ther. 2021;6:406. doi: 10.1038/s41392-021-00818-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00818-7</ArticleId><ArticleId IdType="pmc">PMC8609271</ArticleId><ArticleId IdType="pubmed">34815399</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounika V.L., Kumar V.U., Dhingra S., Ravichandiran V., Pandey K., Parihar V.K., Murti K. CD4&#x2009;+&#x2009;Count: A Variable to Be Considered to Prioritize COVID-19 Vaccination in PLHIV. Curr. Pharmacol. Rep. 2023;9:90&#x2013;97. doi: 10.1007/s40495-023-00312-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40495-023-00312-4</ArticleId><ArticleId IdType="pmc">PMC9944399</ArticleId><ArticleId IdType="pubmed">36844431</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B., Wang C., Tan Y., Chen X., Liu Y., Ning L., Chen L., Li M., Liu Y., Wang G., et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) Front. Immunol. 2020;11:827. doi: 10.3389/fimmu.2020.00827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon C. Fighting COVID-19 exhausts T cells. Nat. Rev. Immunol. 2020;20:277. doi: 10.1038/s41577-020-0304-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0304-7</ArticleId><ArticleId IdType="pmc">PMC7132550</ArticleId><ArticleId IdType="pubmed">32249845</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.C., Devason A.S., Umana I.C., Cox T.O., Dohnalov&#xe1; L., Litichevskiy L., Perla J., Lundgren P., Etwebi Z., Izzo L.T., et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;4867.e4820. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Eteraf-Oskouei T., Najafi M. The relationship between the serotonergic system and COVID-19 disease: A review. Heliyon. 2022;8:e09544. doi: 10.1016/j.heliyon.2022.e09544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2022.e09544</ArticleId><ArticleId IdType="pmc">PMC9132783</ArticleId><ArticleId IdType="pubmed">35652122</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa. Physiol. Rev. 2018;98:477&#x2013;504. doi: 10.1152/physrev.00039.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00039.2016</ArticleId><ArticleId IdType="pmc">PMC5866360</ArticleId><ArticleId IdType="pubmed">29351513</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T., Gonevski M., Clark C., Baitule S., Sharma K., Magar A., Patel K., Sankar S., Kyrou I., Ali A., et al. Hyperbaric oxygen therapy for the treatment of long COVID: Early evaluation of a highly promising intervention. Clin. Med. 2021;21:e629&#x2013;e632. doi: 10.7861/clinmed.2021-0462.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J.P., Snyder J., Schuerer D.J.E., Peters J.S., Bochicchio G.V. Essentials of hyperbaric oxygen therapy: 2019 Review. MOMed. 2019;116:176&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6690283</ArticleId><ArticleId IdType="pubmed">31527935</ArticleId></ArticleIdList></Reference><Reference><Citation>Akarsu S., Tekin L., Ay H., Carli A.B., Tok F., Sim&#x15f;ek K., Kiralp M.Z. The efficacy of hyperbaric oxygen therapy in the management of chronic fatigue syndrome. Undersea Hyperb. Med. 2013;40:197&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">23682549</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta N., Pokharna P., Shetty S.R. Unwinding the potentials of vitamin C in COVID-19 and other diseases: An updated review. Nutr. Health. 2023;29:415&#x2013;433. doi: 10.1177/02601060221139628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02601060221139628</ArticleId><ArticleId IdType="pmc">PMC9713540</ArticleId><ArticleId IdType="pubmed">36445072</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz U., Fatima N., Basharat S., Bibi A., Yu X., Hussain M.I., Nasrullah M. Role of vitamin C in preventing of COVID-19 infection, progression and severity. AIMS Microbiol. 2022;8:108&#x2013;124. doi: 10.3934/microbiol.2022010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/microbiol.2022010</ArticleId><ArticleId IdType="pmc">PMC8995185</ArticleId><ArticleId IdType="pubmed">35496992</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: A prospective, community-based study. BMJ. 2021;11:e048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Mu M., Yang P., Sun Y., Wang R., Yan J., Li P., Hu B., Wang J., Hu C., et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am. J. Gastroenterol. 2020;115:766&#x2013;773. doi: 10.14309/ajg.0000000000000620.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000620</ArticleId><ArticleId IdType="pmc">PMC7172492</ArticleId><ArticleId IdType="pubmed">32287140</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B., Peters J.B., Brink M., Schoon Y., Bleeker-Rovers C.P., Schers H., van Hees H.W.H., van Helvoort H., van den Boogaard M., van der Hoeven H., et al. Comprehensive health assessment 3 months after recovery from acute Coronavirus Disease 2019 (COVID-19) Clin. Infect. Dis. 2020;73:e1089&#x2013;e1098. doi: 10.1093/cid/ciaa1750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#x142;ywaczewska-Jakubowska M., Chudzik M., Babicki M., Kapusta J., Jankowski P. Lifestyle, course of COVID-19, and risk of Long-COVID in non-hospitalized patients. Front. Med. 2022;9:1036556. doi: 10.3389/fmed.2022.1036556.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1036556</ArticleId><ArticleId IdType="pmc">PMC9637668</ArticleId><ArticleId IdType="pubmed">36353225</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E., Andreeva M., Spiridonova E., Bobkova P., Shikhaleva A., El-Taravi Y., Rumyantsev M., Gamirova A., Bairashevskaia A., Petrova P., et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12&#x2009;months after hospital discharge: A prospective, cohort study in Moscow (StopCOVID) BMC Med. 2022;20:244. doi: 10.1186/s12916-022-02448-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto C., Shibata S., Kishi T., Morimoto S., Mogi M., Yamamoto K., Kobayashi K., Tanaka M., Asayama K., Yamamoto E., et al. Long COVID and hypertension-related disorders: A report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertens. Res. 2023;46:601&#x2013;619. doi: 10.1038/s41440-022-01145-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-01145-2</ArticleId><ArticleId IdType="pmc">PMC9793823</ArticleId><ArticleId IdType="pubmed">36575228</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero &#xd3;.J., Navarro-Pardo E., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Cigar&#xe1;n-M&#xe9;ndez M., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 Symptoms: The LONG-COVID-EXP-CM multicenter study. J. Clin. Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2022;28:e619&#x2013;e611. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafi M.B., Javanmard S.H. Post-COVID-19 syndrome mechanisms, prevention and management. Int. J. Prev. Med. 2023;14:59. doi: 10.4103/ijpvm.ijpvm_508_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijpvm.ijpvm_508_21</ArticleId><ArticleId IdType="pmc">PMC10284243</ArticleId><ArticleId IdType="pubmed">37351054</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwatenge C.N., Pate M., Miller L.C., Sang Y. Immunometabolic dysregulation at the intersection of obesity and COVID-19. Front Immunol. 2021;12:732913. doi: 10.3389/fimmu.2021.732913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.732913</ArticleId><ArticleId IdType="pmc">PMC8560738</ArticleId><ArticleId IdType="pubmed">34737743</ArticleId></ArticleIdList></Reference><Reference><Citation>Debski M., Tsampasian V., Haney S., Blakely K., Weston S., Ntatsaki E., Lim M., Madden S., Perperoglou A., Vassiliou V.S. Post-COVID-19 syndrome risk factors and further use of health services in East England. PLOS Global Public Health. 2022;2:e0001188. doi: 10.1371/journal.pgph.0001188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgph.0001188</ArticleId><ArticleId IdType="pmc">PMC10022108</ArticleId><ArticleId IdType="pubmed">36962824</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai D.B.G., Sia I.G., Doubeni C.A., Wieland M.L. Disproportionate impact of COVID-19 on racial and ethnic minority groups in the United States: A 2021 update. J. Racial Ethn. Health Dispar. 2022;9:2334&#x2013;2339. doi: 10.1007/s40615-021-01170-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40615-021-01170-w</ArticleId><ArticleId IdType="pmc">PMC8513546</ArticleId><ArticleId IdType="pubmed">34647273</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas A., Yasa J., Lucas M. Regeneration and repair in the healing lung. Clin Transl. Immunol. 2020;9:e1152. doi: 10.1002/cti2.1152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1152</ArticleId><ArticleId IdType="pmc">PMC7338595</ArticleId><ArticleId IdType="pubmed">32665845</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace W.A., Fitch P.M., Simpson A.J., Howie S.E. Inflammation-associated remodelling and fibrosis in the lung&#x2014;A process and an end point. Int. J. Exp. Pathol. 2007;88:103&#x2013;110. doi: 10.1111/j.1365-2613.2006.00515.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2613.2006.00515.x</ArticleId><ArticleId IdType="pmc">PMC2517298</ArticleId><ArticleId IdType="pubmed">17408453</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua-Huy T., G&#xfc;nther S., Lorut C., Subileau M., Aubourg F., Morbieu C., Marey J., Texereau J., Fajac I., Mouthon L., et al. Distal lung inflammation assessed by alveolar concentration of nitric oxide is an individualised biomarker of severe COVID-19 pneumonia. J. Pers. Med. 2022;12:1631. doi: 10.3390/jpm12101631.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12101631</ArticleId><ArticleId IdType="pmc">PMC9605039</ArticleId><ArticleId IdType="pubmed">36294770</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge S., Wang X., Hou Y., Lv Y., Wang C., He H. Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2. Eur. J. Pharmacol. 2021;896:173897. doi: 10.1016/j.ejphar.2021.173897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.173897</ArticleId><ArticleId IdType="pmc">PMC7826143</ArticleId><ArticleId IdType="pubmed">33497607</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Seethamraju H., Dhody K., Corley M.J., Kazempour K., Lalezari J., Pang A.P.S., Sugai C., Mahyari E., Francisco E.B., et al. CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. Int. J. Infect. Dis. 2021;103:25&#x2013;32. doi: 10.1016/j.ijid.2020.10.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.101</ArticleId><ArticleId IdType="pmc">PMC7654230</ArticleId><ArticleId IdType="pubmed">33186704</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinali D.P., Brown G.M., Pandi-Perumal S.R. Possible application of melatonin in long COVID. Biomolecules. 2022;12:1646. doi: 10.3390/biom12111646.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12111646</ArticleId><ArticleId IdType="pmc">PMC9687267</ArticleId><ArticleId IdType="pubmed">36358996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente-Ros M., Das S., Elias J., Frishman W.H., Aronow W.S. Cardiovascular manifestations of the long COVID syndrome. Cardiol. Rev. 2023 doi: 10.1097/CRD.0000000000000552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CRD.0000000000000552</ArticleId><ArticleId IdType="pubmed">37071080</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Ibnhadjamor H., Jdidi J., Torjmen S., Kraiem S., Bahloul A., Makni A., Kallel N., Moussa N., Boudaya M., et al. Sulodexide significantly improves endothelial dysfunction and alleviates chest pain and palpitations in patients with long-COVID-19: Insights from TUN-EndCOV study. Front. Cardiovasc. Med. 2022;9:866113. doi: 10.3389/fcvm.2022.866113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.866113</ArticleId><ArticleId IdType="pmc">PMC9133483</ArticleId><ArticleId IdType="pubmed">35647070</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M., Vink-Niese A. Cognitive behavioural therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective. Re-analysis of a Cochrane review. Health Psychol. Open. 2019;6:2055102919840614. doi: 10.1177/2055102919840614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2055102919840614</ArticleId><ArticleId IdType="pmc">PMC6498783</ArticleId><ArticleId IdType="pubmed">31080632</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Feasibility of vitamin C in the treatment of post viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients. 2021;13:1154. doi: 10.3390/nu13041154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041154</ArticleId><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Orend&#xe1;&#x10d;ov&#xe1; M., Kva&#x161;&#x148;&#xe1;k E., Vr&#xe1;nov&#xe1; J. Effect of neurofeedback therapy on neurological post-COVID-19 complications (A pilot study) PLoS ONE. 2022;17:e0271350. doi: 10.1371/journal.pone.0271350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0271350</ArticleId><ArticleId IdType="pmc">PMC9328527</ArticleId><ArticleId IdType="pubmed">35895740</ArticleId></ArticleIdList></Reference><Reference><Citation>Dono F., Consoli S., Evangelista G., D&#x2019;Apolito M., Russo M., Carrarini C., Calisi D., De Rosa M., Di Pietro M., De Angelis M.V., et al. New daily persistent headache after SARS-CoV-2 infection: A report of two cases. Neurol. Sci. 2021;42:3965&#x2013;3968. doi: 10.1007/s10072-021-05444-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05444-3</ArticleId><ArticleId IdType="pmc">PMC8280630</ArticleId><ArticleId IdType="pubmed">34264414</ArticleId></ArticleIdList></Reference><Reference><Citation>Krymchantowski A.V., Silva-N&#xe9;to R.P., Jevoux C., Krymchantowski A.G. Indomethacin for refractory COVID or post-COVID headache: A retrospective study. Acta Neurol. Belg. 2022;122:465&#x2013;469. doi: 10.1007/s13760-021-01790-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-021-01790-3</ArticleId><ArticleId IdType="pmc">PMC8453033</ArticleId><ArticleId IdType="pubmed">34546559</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., Alpuente A., Torres-Ferrus M., Pozo-Rosich P. Toward a better understanding of persistent headache after mild COVID-19: Three migraine-like yet distinct scenarios. Headache. 2021;61:1277&#x2013;1280. doi: 10.1111/head.14197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14197</ArticleId><ArticleId IdType="pmc">PMC8444902</ArticleId><ArticleId IdType="pubmed">34363619</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurek M., Rayner C., Freyer A., Taylor S., J&#xe4;rte L., MacDermott N., Delaney B.C. Recommendations for the recognition, diagnosis, and management of long COVID: A Delphi study. Br. J. Gen. Pract. 2021;71:e815&#x2013;e825. doi: 10.3399/BJGP.2021.0265.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0265</ArticleId><ArticleId IdType="pmc">PMC8510689</ArticleId><ArticleId IdType="pubmed">34607799</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist J.T., Collier G.J., Walters H., Kim M., Chen M., Eid G.A., Laws A., Matthews V., Jacob K., Cross S., et al. Lung abnormalities detected with hyperpolarized 129Xe MRI in patients with long COVID. Radiology. 2022;305:709&#x2013;717. doi: 10.1148/radiol.220069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220069</ArticleId><ArticleId IdType="pmc">PMC9134268</ArticleId><ArticleId IdType="pubmed">35608443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E., Hall K.H., Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 &#x2018;long-haulers&#x2019;? Chronic Dis. Transl. Med. 2021;7:14&#x2013;26. doi: 10.1016/j.cdtm.2020.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas R., Williams M., Aldous J., Yanagisawa Y., Kumar R., Forsyth R., Chater A. A randomised, double-blind, placebo-controlled trial evaluating concentrated phytochemical-rich nutritional capsule in addition to a probiotic capsule on clinical outcomes among individuals with COVID-19-The UK Phyto-V study. COVID. 2022;2:433&#x2013;449. doi: 10.3390/covid2040031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid2040031</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O., Stehlik P., Clark J., Alcorn K., Glasziou P. Effect of covid-19 vaccination on long covid: Systematic review. BMJ Med. 2023;2:e000385. doi: 10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Perrodeau E., Saldanha J., Pane I., Ravaud P. Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: Target trial emulation based on ComPaRe e-cohort. BMJ Med. 2023;2:e000229. doi: 10.1136/bmjmed-2022-000229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000229</ArticleId><ArticleId IdType="pmc">PMC9978748</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T., Hirose M., Inoue Y., Kunishima H., Otsubo T., Matsuda T. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID. J. Med. Virol. 2022;94:3416&#x2013;3420. doi: 10.1002/jmv.27689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27689</ArticleId><ArticleId IdType="pmc">PMC9088489</ArticleId><ArticleId IdType="pubmed">35238053</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayyerabadi M., Fourcade L., Joshi S.A., Chandrasekaran P., Chakravarti A., Masse C., Paul M.L., Houle J., Boubekeur A.M., DuSablon C., et al. Vaccination after developing long COVID: Impact on clinical presentation, viral persistence, and immune responses. Int. J. Infect. Dis. 2023;136:136&#x2013;145. doi: 10.1016/j.ijid.2023.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.09.006</ArticleId><ArticleId IdType="pubmed">37717649</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>